Learn More
Medchemexpress LLC 7-[(4,5-dihydro-2-methyl-4-oxo-2H-thieno[2,3-g]indol-7-yl)oxy]-N-(phenylsulfonyl)-9-heptanamide | 910562-18-4 | MFCD27572791 | 99.7% | 429.57 | 5 MG

Supplier: Medchemexpress LLC HY198645MG
Aganepag is a potent Prostanoid EP2 receptor agonist with an EC50 of 0.19 nM, showing no activity at the EP4 receptor. It is used in the research of wound healing, scar reduction, scar prevention, and wrinkle treatment and prevention.
- Potent Prostanoid EP2 receptor agonist with an EC50 of 0.19 nM.
- No activity at EP4 receptor.
- Can be used in wound healing research.
- Applicable for scar reduction and prevention studies.
- Useful for wrinkle treatment and prevention research.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.